Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,477,000
-24,000 (-1.60%)
At close: Sep 3, 2026
Samsung Biologics Employees
Samsung Biologics had 5,047 employees as of June 30, 2025. The number of employees increased by 277 or 5.81% since the number was reported on December 31, 2024.
Employees
5,047
Change
277
Growth
5.81%
Revenue / Employee
961.55M KRW
Profits / Employee
372.57M KRW
Market Cap
68.30T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 5,047 | 277 | 5.81% |
| Dec 31, 2024 | 4,770 | 1,884 | 65.28% |
| Dec 31, 2020 | 2,886 | 1,135 | 64.82% |
| Dec 31, 2017 | 1,751 | 413 | 30.87% |
| Dec 31, 2016 | 1,338 | - | - |
Samsung Biologics News
- 3 days ago - Samsung Biologics Publishes PolyPeptide Offer Prospectus; Sets Tender Period - Nasdaq
- 6 days ago - Samsung Biologics Plans $2 Billion Fundraising for PolyPeptide Acquisition - GuruFocus
- 6 days ago - Samsung Biologics Plans $21.7 Billion Fundraising for Growth Strategy - GuruFocus
- 6 weeks ago - Samsung Biologics Slides: Q2 2026 - Filings
- 6 weeks ago - Samsung Biologics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Samsung Biologics Delivers Solid Q2 2026 Growth, Operating Profit Rises - Nasdaq
- 6 weeks ago - Samsung Biologics (005940) Proposes $1.8 Billion Acquisition of Polypeptide Group - GuruFocus
- 6 weeks ago - Samsung Biologics to Acquire Peptide Group for $1.8 Billion (SMCI) - GuruFocus